Deficiency in LRP6-Mediated Wnt Signaling Contributes to Synaptic Abnormalities and Amyloid Pathology in Alzheimer's Disease

Chia-Chen Liu, Chih Wei Tsai, Ferenc Deak, Justin Rogers, Michael Penuliar, You Me Sung, James N. Maher, Yuan Fu, Xia Li, Huaxi Xu, Steven Estus, Hyang Sook Hoe, John D. Fryer, Takahisa Kanekiyo, Guojun D Bu

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

Alzheimer's disease (AD) is an age-related neurological disorder characterized by synaptic loss and dementia. The low-density lipoprotein receptor-related protein 6 (LRP6) is an essential coreceptor for Wnt signaling, and its genetic variants have been linked to AD risk. Here we report that neuronal LRP6-mediated Wnt signaling is critical for synaptic function and cognition. Conditional deletion of Lrp6 gene in mouse forebrain neurons leads to age-dependent deficits in synaptic integrity and memory. Neuronal LRP6 deficiency in an amyloid mouse model also leads to exacerbated amyloid pathology due to increased APP processing to amyloid-β. In humans, LRP6 and Wnt signaling are significantly downregulated in AD brains, likely by a mechanism that depends on amyloid-β. Our results define a critical pathway in which decreased LRP6-mediated Wnt signaling, synaptic dysfunction, and elevated Aβ synergistically accelerate AD progression and suggest that restoring LRP6-mediated Wnt signaling can be explored as a viable strategy for AD therapy.

Original languageEnglish (US)
Pages (from-to)63-77
Number of pages15
JournalNeuron
Volume84
Issue number1
DOIs
StatePublished - Oct 1 2014

Fingerprint

Low Density Lipoprotein Receptor-Related Protein-6
Amyloid
Alzheimer Disease
Pathology
Protein Deficiency
Critical Pathways
Gene Deletion
Prosencephalon
Nervous System Diseases
Cognition
Dementia
Disease Progression
Down-Regulation
Neurons
Brain

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Deficiency in LRP6-Mediated Wnt Signaling Contributes to Synaptic Abnormalities and Amyloid Pathology in Alzheimer's Disease. / Liu, Chia-Chen; Tsai, Chih Wei; Deak, Ferenc; Rogers, Justin; Penuliar, Michael; Sung, You Me; Maher, James N.; Fu, Yuan; Li, Xia; Xu, Huaxi; Estus, Steven; Hoe, Hyang Sook; Fryer, John D.; Kanekiyo, Takahisa; Bu, Guojun D.

In: Neuron, Vol. 84, No. 1, 01.10.2014, p. 63-77.

Research output: Contribution to journalArticle

Liu, C-C, Tsai, CW, Deak, F, Rogers, J, Penuliar, M, Sung, YM, Maher, JN, Fu, Y, Li, X, Xu, H, Estus, S, Hoe, HS, Fryer, JD, Kanekiyo, T & Bu, GD 2014, 'Deficiency in LRP6-Mediated Wnt Signaling Contributes to Synaptic Abnormalities and Amyloid Pathology in Alzheimer's Disease', Neuron, vol. 84, no. 1, pp. 63-77. https://doi.org/10.1016/j.neuron.2014.08.048
Liu, Chia-Chen ; Tsai, Chih Wei ; Deak, Ferenc ; Rogers, Justin ; Penuliar, Michael ; Sung, You Me ; Maher, James N. ; Fu, Yuan ; Li, Xia ; Xu, Huaxi ; Estus, Steven ; Hoe, Hyang Sook ; Fryer, John D. ; Kanekiyo, Takahisa ; Bu, Guojun D. / Deficiency in LRP6-Mediated Wnt Signaling Contributes to Synaptic Abnormalities and Amyloid Pathology in Alzheimer's Disease. In: Neuron. 2014 ; Vol. 84, No. 1. pp. 63-77.
@article{223f42f6f9a94bfca63ad666bfa20c5f,
title = "Deficiency in LRP6-Mediated Wnt Signaling Contributes to Synaptic Abnormalities and Amyloid Pathology in Alzheimer's Disease",
abstract = "Alzheimer's disease (AD) is an age-related neurological disorder characterized by synaptic loss and dementia. The low-density lipoprotein receptor-related protein 6 (LRP6) is an essential coreceptor for Wnt signaling, and its genetic variants have been linked to AD risk. Here we report that neuronal LRP6-mediated Wnt signaling is critical for synaptic function and cognition. Conditional deletion of Lrp6 gene in mouse forebrain neurons leads to age-dependent deficits in synaptic integrity and memory. Neuronal LRP6 deficiency in an amyloid mouse model also leads to exacerbated amyloid pathology due to increased APP processing to amyloid-β. In humans, LRP6 and Wnt signaling are significantly downregulated in AD brains, likely by a mechanism that depends on amyloid-β. Our results define a critical pathway in which decreased LRP6-mediated Wnt signaling, synaptic dysfunction, and elevated Aβ synergistically accelerate AD progression and suggest that restoring LRP6-mediated Wnt signaling can be explored as a viable strategy for AD therapy.",
author = "Chia-Chen Liu and Tsai, {Chih Wei} and Ferenc Deak and Justin Rogers and Michael Penuliar and Sung, {You Me} and Maher, {James N.} and Yuan Fu and Xia Li and Huaxi Xu and Steven Estus and Hoe, {Hyang Sook} and Fryer, {John D.} and Takahisa Kanekiyo and Bu, {Guojun D}",
year = "2014",
month = "10",
day = "1",
doi = "10.1016/j.neuron.2014.08.048",
language = "English (US)",
volume = "84",
pages = "63--77",
journal = "Neuron",
issn = "0896-6273",
publisher = "Cell Press",
number = "1",

}

TY - JOUR

T1 - Deficiency in LRP6-Mediated Wnt Signaling Contributes to Synaptic Abnormalities and Amyloid Pathology in Alzheimer's Disease

AU - Liu, Chia-Chen

AU - Tsai, Chih Wei

AU - Deak, Ferenc

AU - Rogers, Justin

AU - Penuliar, Michael

AU - Sung, You Me

AU - Maher, James N.

AU - Fu, Yuan

AU - Li, Xia

AU - Xu, Huaxi

AU - Estus, Steven

AU - Hoe, Hyang Sook

AU - Fryer, John D.

AU - Kanekiyo, Takahisa

AU - Bu, Guojun D

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Alzheimer's disease (AD) is an age-related neurological disorder characterized by synaptic loss and dementia. The low-density lipoprotein receptor-related protein 6 (LRP6) is an essential coreceptor for Wnt signaling, and its genetic variants have been linked to AD risk. Here we report that neuronal LRP6-mediated Wnt signaling is critical for synaptic function and cognition. Conditional deletion of Lrp6 gene in mouse forebrain neurons leads to age-dependent deficits in synaptic integrity and memory. Neuronal LRP6 deficiency in an amyloid mouse model also leads to exacerbated amyloid pathology due to increased APP processing to amyloid-β. In humans, LRP6 and Wnt signaling are significantly downregulated in AD brains, likely by a mechanism that depends on amyloid-β. Our results define a critical pathway in which decreased LRP6-mediated Wnt signaling, synaptic dysfunction, and elevated Aβ synergistically accelerate AD progression and suggest that restoring LRP6-mediated Wnt signaling can be explored as a viable strategy for AD therapy.

AB - Alzheimer's disease (AD) is an age-related neurological disorder characterized by synaptic loss and dementia. The low-density lipoprotein receptor-related protein 6 (LRP6) is an essential coreceptor for Wnt signaling, and its genetic variants have been linked to AD risk. Here we report that neuronal LRP6-mediated Wnt signaling is critical for synaptic function and cognition. Conditional deletion of Lrp6 gene in mouse forebrain neurons leads to age-dependent deficits in synaptic integrity and memory. Neuronal LRP6 deficiency in an amyloid mouse model also leads to exacerbated amyloid pathology due to increased APP processing to amyloid-β. In humans, LRP6 and Wnt signaling are significantly downregulated in AD brains, likely by a mechanism that depends on amyloid-β. Our results define a critical pathway in which decreased LRP6-mediated Wnt signaling, synaptic dysfunction, and elevated Aβ synergistically accelerate AD progression and suggest that restoring LRP6-mediated Wnt signaling can be explored as a viable strategy for AD therapy.

UR - http://www.scopus.com/inward/record.url?scp=84907985969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907985969&partnerID=8YFLogxK

U2 - 10.1016/j.neuron.2014.08.048

DO - 10.1016/j.neuron.2014.08.048

M3 - Article

C2 - 25242217

AN - SCOPUS:84907985969

VL - 84

SP - 63

EP - 77

JO - Neuron

JF - Neuron

SN - 0896-6273

IS - 1

ER -